Adam Steinmetz is named as a lobbyist on federal disclosure filings for 46 clients through Brownstein Hyatt Farber Schreck, LLP. The most recent filing naming them posted in November 2026. Issues reported include Health Issues, Pharmacy, Trade (domestic/foreign) and Agriculture.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| IMMIX BIOPHARMA, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2026 | Pharmacy, Health Issues |
| TULANE UNIVERSITY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Education |
| CENCORA, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| PERNOD RICARD USA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Agriculture, Trade (domestic/foreign) |
| BECTON, DICKINSON AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| TOLMAR, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy |
| NOVARTIS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ABBVIE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| MEDEXPERT INTERNATIONAL, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Veterans |
| LIFEPOINT HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| KYVERNA THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| NORTHERN COMPASS GROUP LLC OBO PETERSBURG MEDICAL CENTER | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| CENTENE CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| FERRING PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| PIM BRANDS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Food Industry (safety, labeling, etc.), Health Issues |
| ELI LILLY AND COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Pharmacy, Health Issues |
| CHSPSC, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Medical/Disease Research/Clinical Labs |
| SOUTHEAST ALASKA REGIONAL HEALTH CONSORTIUM | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Real Estate/Land Use/Conservation |
| ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Taxation/Internal Revenue Code, Trade (domestic/foreign), Pharmacy |
| TAPESTRYHEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| TENET BUSINESS SERVICES CORPORATION | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ASANA VOICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| TEXAS CHILDREN'S HOSPITAL | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| UNIVERSITY OF COLORADO HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| HARMONY BIOSCIENCES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Veterans, Health Issues |
| CAREQUEST INSTITUTE FOR ORAL HEALTH, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| THE JEWISH FEDERATIONS OF NORTH AMERICA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2026 | Health Issues |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2026 | Health Issues |
| MUSCLESOUND, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| DEACON HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| CONSENSUS CLOUD SOLUTIONS | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| EDERA L3C | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Science/Technology |
| PIERRE FABRE PHARMACEUTICALS INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Pharmacy |
| RED ROCK RESORTS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Gaming/Gambling/Casino |
| ARDENT HEALTH SERVICES | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2026 | Health Issues |
| CLEAR | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2025 | Aviation/Airlines/Airports |
| TYSON FOODS INC | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q4 2025 | Labor Issues/Antitrust/Workplace |
| CINNAMON HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2025 | Veterans, Health Issues |
| AMERICAN POPS ORCHESTRA | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q3 2025 | Arts/Entertainment |
| LEARNED HAND | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Science/Technology |
| PARTICLE HEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Health Issues |
| SPARK THERAPEUTICS, INC. | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Health Issues |
| THE SCOTTS MIRACLE-GRO COMPANY | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q2 2025 | Banking |
| BAYLOR COLLEGE OF MEDICINE | BROWNSTEIN HYATT FARBER SCHRECK, LLP | Q1 2025 | Taxation/Internal Revenue Code |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 35 | 1 |
| 2025 | 37 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 10 | $2K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Adam Steinmetz. See the Capitol Clarity rankings and method.